The online version of this article (doi:10.1186/1477-7819-10-62) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
All authors substantially contributed to the manuscript and approved the final submission.
Resistance of breast cancer cells to the available chemotherapeutics is a major obstacle to successful treatment. Recent studies have shown that magnetic nanoparticles might have significant application in different medical fields including cancer treatment. The goal of this study is to verify the ability of magnetic nanoparticles to sensitize cancer cells to the clinically available chemotherapy.
The role of iron oxide nanoparticles, static magnetic field, or a combination in the enhancement of the apoptotic potential of doxorubicin against the resistant breast cancer cells, MCF-7 was evaluated using the MTT assay and the propidium iodide method.
In the present study, results revealed that pre-incubation of MCF-7 cells with iron oxide nanoparticles before the addition of doxorubicin did not enhance doxorubicin-induced growth inhibition. Pre-incubation of MCF-7 cells with iron oxide nanoparticles followed by a static magnetic field exposure significantly (P < 0.05) increased doxorubicin-induced cytotoxicity. Sensitization with pre-exposure to the magnetic field was dose-dependent where the highest cytotoxicity was seen at 1 tesla. Further experiments revealed that the anti-proliferative effect of this treatment procedure is due to induction of apoptotic cell death.
These results might point to the importance of combining magnetic nanoparticles with a static magnetic field in treatment of doxorubicin-refractory breast cancer cells.
Desantis C, Siegel R, Bandi P, Jemal A: Breast cancer statistics, 2011. CA Cancer J Clin. 2011, 2011: 20134-
Jordan Breast Cancer Program: http://www.jbcp.jo/node/14
Peng XH, Qian X, Mao H, Wang AY, Chen ZG, Nie S, Shin DM: Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomed. 2008, 3: 311-321.
Park SI, Kwon BJ, Park JH, Jung H, Yu KH: Synthesis and characterization of 3-[131I]iodo-L-tyrosine grafted Fe3O4@SiO2 nanocomposite for single photon emission computed tomography (SPECT) and magnetic resonance imaging (MRI). SO–J Nanosci Nanotechnol. 2011, 11: 1818-1821. 10.1166/jnn.2011.3416. CrossRef
Gong X, Peng S, Wen W, Sheng P, Li W: Design and fabrication of magnetically functionalized core/shell microspheres for smart drug delivery. Adv Funct Mater. 2009, 19: 292-297. 10.1002/adfm.200801315. CrossRef
Souza GR, Christianson DR, Staquicini FI, Ozawa MG, Snyder EY, Sidman RL, Miller JH, Arap W, Pasqualini R: Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc Natl Acad Sci USA. 2006, 103: 1215-1220. 10.1073/pnas.0509739103. PubMedCentralCrossRefPubMed
DeNardo SJ, DeNardo GL, Miers LA, Natarajan A, Foreman AR, Gruettner C, Adamson GN, Ivkov R: Development of tumor targeting bioprobes ((111)In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin Cancer Res. 2005, 11: 7087s-7092s. 10.1158/1078-0432.CCR-1004-0022. CrossRefPubMed
Dennis CL, Jackson AJ, Borchers JA, Hoopes PJ, Strawbridge R, Foreman AR, van Lierop J, Gruttner C, Ivkov R: Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia. Nanotechnology. 2009, 20: 395103-10.1088/0957-4484/20/39/395103. PubMedCentralCrossRefPubMed
Liu T-Y, Liu K-H, Liu D-M, Chen S-Y, Chen I-W: Temperature-sensitive nanocapsules for controlled drug release caused by magnetically triggered structural disruption. Adv Funct Mater. 2008, 18: 1-8.
Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, von Deimling A, Waldoefner N, Felix R, Jordan A: Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol. 2007, 81: 53-60. CrossRefPubMed
Gillespie SK, Zhang XD, Hersey P: Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in melanoma cells. Mol Cancer Ther. 2004, 3: 1651-1658. PubMed
Grzegorczyk J: Apoptosis-programmed cell death (PCD)—current conceptions. Int J Biomed Res. 1999, 1: 2-7.
Jajte JM: Chemical-induced changes in intracellular redox state and in apoptosis. Int J Occup Med Environ Health. 1997, 10: 203-212. PubMed
Sarafian TA, Bredesen DE: Is apoptosis mediated by reactive oxygen species?. Free Radical Res. 1994, 21: 1-8. 10.3109/10715769409056549. CrossRef
Blumenthal NC, Ricci J, Breger L, Zychlinsky A, Solomon H, Chen GG, Kuznetsov D, Dorfman R: Effects of low-intensity AC and/or DC electromagnetic fields on cell attachment and induction of apoptosis. Bioelectromagnetics. 1997, 18: 264-272. 10.1002/(SICI)1521-186X(1997)18:3<264::AID-BEM10>3.0.CO;2-P. CrossRefPubMed
Sarvestani AS, Abdolmaleki P, Mowla SJ, Ghanati F, Heshmati E, Tavasoli Z, Jahromi AM: Static magnetic fields aggravate the effects of ionizing radiation on cell cycle progression in bone marrow stem cells. Micron. 2010, 2: 101-104. CrossRef
Chionna A, Dwikat M, Panzarini E, Tenuzzo B, Carla EC, Verri T, Pagliara P, Abbro L, Dini L: Cell shape and plasma membrane alterations after static magnetic fields exposure. Eur J Histochem. 2003, 47: 299-308. PubMed
- Magnetic nanoparticles sensitize MCF-7 breast cancer cells to doxorubicin-induced apoptosis
Nizar M Mhaidat
M-Ali H Al-Akhras
Ahmad N Aldaher
Fawzi M Alsheyab
- BioMed Central
Neu im Fachgebiet Chirurgie
Mail Icon II